02493.HK
MABWELL-B
HKSE · Healthcare · Biotechnology · CN
HKD 20.78
+0.58%Margins
Gross margin
74.5%
EBITDA margin
-79.6%
EBIT margin
-98.4%
Net margin
-107.5%
FCF margin
-102.7%
-107.6%
Return on equity
-17.8%
Return on assets
-20.3%
Return on invested capital
0.18x
Asset turnover
-HKD 892.9M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026